PolyTherics makes appointment
This article was originally published in Scrip
PolyTherics, a UK-based biopharmaceutical company that applies precision chemistry to develop protein and peptide-based drugs, has named Dr John Burt chief business officer. He was previously CEO of Thiakis, a company which he co-founded with Professor Steve Bloom of Imperial College in 2004 and sold to Wyeth in 2008. Dr Burt has also previously worked at Imperial Innovations, GlaxoSmithKline and Vernalis.